The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation

American Journal of Transplantation

Volumn 5, Issue 3, 2005, Pages 537-543

  Fisher, Andrew J ^a,b   Rutherford, Robert M ^b   Bozzino, Joseph ^c   Parry, Gareth ^b   Dark, John H ^a,b   Corris, Paul A ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bronchiolitis obliterans syndrome; Immunosuppression; Lung transplantation

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; BONE MARROW SUPPRESSION; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEART LUNG TRANSPLANTATION; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPH NODE IRRADIATION; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; SAFETY; THRUSH; URINARY TRACT INFECTION;

EID: 14644391619     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00709.x     Document Type: Article

References (14)

1. Trulock E, Edwards LB, Taylor DO et al. The registry of the international society for heart and lung transplantation: Adult lung and heart-lung transplant report 2003. J Heart Lung Transplant 2003; 22: 625-635.
2. Halperin EC. Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: A review. Clin Radiol 1985; 36: 125-130.
3. Tochner Z, Slavin S. Immune modulation by ionized irradiation. Curr Opin Immunol 1988; 1: 261-268.
4. Wolden SL, Tate SL, Hunt SA et al. Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. Int J Rad Oncol, Biol, Phys 1997; 39: 953-960.
5. Levin B, Hoppe RT, Collins G et al. Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone. Lancet 1985; 2: 1321-5.
6. Diamond DA, Michalski JM, Lynch JP et al. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. Int J Rad Oncol, Biol, Phys 1998; 41: 795-800.
7. Estenne M, Mauver JR, Boehler A et al. Bronchiolitis Obliterans Syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
8. Fuks Z, Strober S, Bobrove A. Long-term effects of radiation on T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest 1976; 58: 803-814.
9. Field E, Becker G. The immunosuppressive mechanism of total lymphoid irradiation. I. The effect on IL-2 production and IL-2 receptor expression. Transplantation 1989; 48: 499-505.
10. Slavin S, Strober S, Fuks Z et al. Immunosuppression and organ transplantation tolerance using total lymphoid irradiation. Diabetes 1980; 29(Suppl 1): 121-123.
11. Najarian JS, Sutherland DE, Fergnson RM et al. Total lymphoid irradiation and kidney transplantation: A clinical experience. Transplant Proc 1981; 13(1 Pt 1): 417-424.
12. Madden BP et al. Intermediate term results of total lymphoid irradiation for the treatment of non-specific graft dysfunction after heart transplantation. Eur J Cardiothorac Surg 1999; 15: 663-666.
13. Valentine VG, Robbins RC, Wehner JH et al. Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts [comment]. Chest 1996; 109: 1184-1189.
14. Keogh AM, Arnold RH, Macdonald PS et al. A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation. J Heart Lung Transplant 2001; 20: 1331-1334.